Core Laboratories Q2 2024 Adj EPS $0.22 Beats $0.21 Estimate, Sales $130.577M Miss $132.170M Estimate
Core Laboratories Q2 2024 Adj EPS $0.22 Beats $0.21 Estimate, Sales $130.577M Miss $132.170M Estimate
core laboratories 2024年Q2调整每股收益为0.22美元，超过了0.21美元的估计，销售额为13057.7万美元，未达到13217万美元的估计。
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.21 by 4.76 percent. This is a 4.76 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $130.577 million which missed the analyst consensus estimate of $132.170 million by 1.21 percent. This is a 2.11 percent increase over sales of $127.881 million the same period last year.
Core Laboratories（纽交所：CLB）报告季度每股收益为0.22美元，超过分析师一致预期的0.21美元，增长了4.76％。 这是比去年同期每股收益0.21美元增长4.76％。 该公司季度销售额为13057.7万美元，较分析师一致预期的13217万美元低1.21％。 这是与去年同期销售额12788.1万美元相比增长了2.11％。